Monitoring blood sugar swings to predict type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 39 years old
- You do not currently have diabetes based on standard diagnosis criteria
- Your blood tests show diabetes-related autoantibodies (IAA, GADA, IA-2A, and/or ZnT8A) that stay positive
- If you are pregnant or breastfeeding (or recently postpartum), you cannot join
- You should not use medicines that affect the immune system or blood sugar (like steroids or diabetes pills)
- You should not have had major stomach surgery for weight loss (like gastric bypass/banding) or pancreas surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with type 1 diabetes are currently treated and their overall metabolic health (like blood sugar control). By participating, you'll help doctors understand what treatments work best and identify areas for improvement.
This study uses a continuous glucose monitor (a small sensor that tracks blood sugar levels) along with a special drink test to find early signs of diabetes. It may help people who are at risk or have early blood sugar problems get a clearer picture of their health.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study follows people of all ages who have a positive islet autoantibody test but no diabetes symptoms yet. It aims to track them over time to learn more about how type 1 diabetes develops, which may lead to better prevention and care.
This study tests a new wearable sensor to see if it can help people with type 1 diabetes better track their blood sugar levels. It might lead to easier and more accurate glucose monitoring.
Hear when a new Type1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.